HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders
Breast Cancer Update
00:00
ER testing and effects of degraders on assays
Discussion of how fulvestrant/CERDs/PROTACs lower measurable ER and implications for repeat biopsies and ER status.
Play episode from 05:12
Transcript
